Cargando…

Analysis of biologic therapy in rheumatoid arthritis in a southern Spanish hospital population

Detalles Bibliográficos
Autores principales:	Uceda-Montañés, J, Hernández-Sánchez, R, Rodríguez-Montero, S, Velloso-Feijoo, M L, Muñoz-Jimenez, A, Martínez-Perez, R, Marenco, J L
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3007820/ http://dx.doi.org/10.1186/1479-5876-8-S1-P72

Ejemplares similares

Juvenile idiopathic arthritis treated with biological therapies
por: Velloso Feijoo, Maria Luisa, et al.
Publicado: (2012)

Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
por: Martínez-Pérez, Rosalía, et al.
Publicado: (2011)

Clinical and economic efficiency to reduce dose etanercept and adalimumab in patients with rheumatoid arthritis
por: Martínez-Pérez, Rosalía, et al.
Publicado: (2012)

Clinical and functional effectiveness of anti-TNF therapy in patients with rheumatoid arthritis
por: Martínez-Pérez, Rosalia, et al.
Publicado: (2011)

Seronegative and seropositive rheumatoid arthritis treated with rituximab
por: Velloso Feijoo, Maria Luisa, et al.
Publicado: (2012)

Wegener granulomatosis: type of presentation and initial treatment in a series of 23 cases
por: Martínez-Pérez, Rosalia, et al.
Publicado: (2012)

Changes in nailfold videocapillaroscopy in patients with granulomatosis with polyangiitis (Wegener’s): an observational study
por: Uceda, Julia, et al.
Publicado: (2012)

The reason to stop infliximab is clearly related to the existence of new alternatives: a correspondence analysis of biologics, reasons to stop, and time periods
por: Uceda, Julia, et al.
Publicado: (2012)

Rituximab reduces the hospitalization in patients with systemic lupus erythematosus
por: Martínez-Pérez, R, et al.
Publicado: (2010)

Prediction of treatment response by anticitrullinated protein antibodies (ACPA) levels among patients with rheumatoid arthritis
por: Hernández, Raquel, et al.
Publicado: (2012)

Rituximab is effective in the treatment of nephritis in lupus patients, refractory to conventional immunosuppressive therapy
por: Martínez, R, et al.
Publicado: (2010)

Interstitial lung disease in patients with scleroderma - Treatment with rituximab
por: Muñoz, A, et al.
Publicado: (2010)

The AIRE gene and susceptibility to rheumatoid arthritis in the Spanish population
por: Torres, Belen, et al.
Publicado: (2011)

Rituximab reduces anti-cardiolipin levels in patients with systemic lupus erythematosus
por: Martínez-Pérez, R, et al.
Publicado: (2010)

Response measures influence comparative effectiveness of biological drugs in rheumatoid arthritis
por: Canhao, Helena, et al.
Publicado: (2012)

Modulation of the gene expression pattern in peripheral blood mononuclear cells by biologicals in rheumatoid arthritis
por: Kekow, J, et al.
Publicado: (2003)

Analysis of IL-10 gene variants in rheumatoid arthritis
por: Huizinga, T, et al.
Publicado: (2003)

Caspase-1 is active since the early phase of rheumatoid arthritis
por: Cascão, R, et al.
Publicado: (2010)

Transcriptional response to hypoxia of normal and rheumatoid arthritis synovial fibroblasts
por: Del Rey, M J, et al.
Publicado: (2010)

The importance of cell surface RANKL in rheumatoid arthritis
por: Krystufkova, O, et al.
Publicado: (2005)

Comparison of the nodule and synovial lesions of rheumatoid arthritis
por: Highton, J, et al.
Publicado: (2003)

Collagenous colitis and rheumatoid arthritis: is there a connection?
por: Wollheim, F, et al.
Publicado: (2003)

IL-15 and its role in rheumatoid arthritis
por: Kurowska-Stolarska, M, et al.
Publicado: (2003)

Spondyloarthropathy and rheumatoid arthritis: two different diseases, a similar cytokine network
por: Moura, R A, et al.
Publicado: (2010)

Significance of fatigue in patients with rheumatoid arthritis
por: Singh, G, et al.
Publicado: (2003)

Rheumatoid arthritis and risk factors for low bone mineral density
por: Arinoviche, R
Publicado: (2004)

Repeated B-cell depletion with rituximab in rheumatoid arthritis
por: Edwards, J, et al.
Publicado: (2003)

Clinical depiction, treatment and long term follow up characterization of a group of enthesitis related arthritis - juvenile idiopathic arthritis patients from a spanish pediatric tertiary hospital
por: Baldizon, Samuel Hernandez, et al.
Publicado: (2014)

Signaling pathways involved in TRAIL-induced rheumatoid arthritis synovial fibroblast proliferation
por: Morel, J, et al.
Publicado: (2005)

Synovial fibroblast hyperplasia correlates with rheumatoid arthritis duration and activity and is partially reversed by anti-TNF therapy
por: Izquierdo, E, et al.
Publicado: (2010)

Cytokine pattern in very early rheumatoid arthritis favours B cell activation and survival
por: Moura, R A, et al.
Publicado: (2010)

IL-1 but not IL-18 induces osteoprotegerin and TRAIL in rheumatoid arthritis synovial fibroblasts
por: Morel, J, et al.
Publicado: (2003)

Systemic-onset juvenile rheumatoid arthritis and ANCA-associated glomerulonephritis
por: Belot, A, et al.
Publicado: (2008)

The functions of the post-translational modifications in rheumatoid arthritis
por: Aratani, Satoko, et al.
Publicado: (2012)

Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis
por: Pers, Yves-Marie, et al.
Publicado: (2011)

Circulating levels of IL-7 in rheumatoid arthritis
por: Churchman, S, et al.
Publicado: (2007)

Impaired early B-cell tolerance in patients with rheumatoid arthritis
por: Samuels, J, et al.
Publicado: (2005)

Role of IL-10 as a susceptibility factor for rheumatoid arthritis and cardiovascular disease
por: Kurreeman, FAS, et al.
Publicado: (2005)

Diagnostic value of different anti-citrullinated peptides antibodies in rheumatoid arthritis
por: Ruiz-Ortiz de Arrizabaleta, Estíbaliz, et al.
Publicado: (2011)

Polymorphism within the telomeric MHC and expression of rheumatoid arthritis candidate genes
por: Mewar, D, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_kv6jldclj2lv6k7upkficp48gq